Drug Trial Radar · NCT01461980
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Last checked: Nov 19, 2026Latest source record: Dec 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,648
Actual
Start
Sep 28, 2011
Primary completion
May 8, 2014
Study completion May 8, 2014
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Oct 28, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 10 years, up to 12 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a clinical study to assess the safety, tolerance and immunogenic response to MCV4(quadrivalent meningococcal polysaccharide conjugate, meningococcal serogroups A,C,Y, and W135), Tdap (diphtheria, tetanus, and acellular pertussis), and bivalent rLP2086 vaccine. Healthy male and female subjects, between the ages of 10 to 12 years old, will be randomized into 1 of 3 groups. The subjects, investigators, site staff and sponsor will be blinded to all injections given throughout the study. An unblinded administrator will be responsible to administer the vaccinations to all subjects and will be unblinded to the subject randomization in order to determine which subjects were in randomized to group 3 so they may receive their catch-up vaccinations of MCV4 and Tdap. A final telephone contact will be conducted with all subjects 6-months post their last vaccination to obtain safety information.
Conditions
- Vaccines
- Meningococcal Vaccines
Interventions
rLP2086 + MCV4 + TdapBiological
At visit 1, group 1 will receive MCV4 + Tdap vaccines concomitantly with an injection of rLP2086. At visits 3 and 5 (Months 2 and 6), group 1 will receive an injection of rLP2086.
MCV4 + Tdap + salineBiological
At visit 1, group 2 will receive MCV4 + Tdap vaccines concomitantly with an injection of saline. At visits 3 and 5 (months 2 and 6), this group will receive a saline injection only.
rLP2086 + salineBiological
At visit 1, group 3 will receive 2 injections of saline concomitantly with an injection of rLP2086. At visits 3 and 5 (Months 2 and 6), group 3 will receive an injection of rLP2086. Subjects randomized to this group will receive MCV4 and Tdap following their final visit blood draw (Visit 6).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric Mean Concentrations (GMC) for Diphtheria and Tetanus AntigensTime frame: 1 Month after Vaccination 1
- Geometric Mean Concentrations (GMC) for Acellular Pertussis AntigensTime frame: 1 Month after Vaccination 1
- Geometric Mean Titer (GMT) for Meningococcal Conjugate Vaccine (MCV4) AntigensTime frame: 1 Month after Vaccination 1
- Serum Bactericidal Assay Using Human Complement (hSBA) GMTs of PMB80 [A22] and PMB2948 [B24] 1 Month After Vaccination 3Time frame: 1 Month after Vaccination 3
Locations
117 sites in 1 country. Site status is shown where the registry gives one.
Radiant Research, Inc.
Birmingham, Alabama
Costal Clinical Research, Inc.
Daphne, Alabama
Clinical Research Advantage Inc/ East Valley Family Physicians, PLC
Chandler, Arizona
Radiant Research, Inc.
Chandler, Arizona
Clinical Research Advantage, Inc./Mesa Family Medical Center, PC
Mesa, Arizona
Clinical Research Advantage, Inc./Desert
Mesa, Arizona
Radiant Research, Inc.
Tucson, Arizona
Radiant Research, Inc.
Tucson, Arizona
The Children's Clinic of Jonesboro, PA
Jonesboro, Arkansas
Arkansas Pediatric Clinic
Little Rock, Arkansas
Kaiser Permanente Fresno
Fresno, California
Kaiser Permanente Hayward
Hayward, California
Pediatric Care Medical Group
Huntington Beach, California
Loma Linda University
Loma Linda, California
Loma Linda University Health Care Pediatric Clinic
Loma Linda, California
Loma Linda University Medical Center
Loma Linda, California
Loma Linda University Health Care - Moreno Valley Pediatrics
Moreno Valley, California
Bayview Research Group, LLC
Paramount, California
Center for Clinical Trials, LLC
Paramount, California
Kaiser Permanente Sacramento
Sacramento, California
California Research Foundation
San Diego, California
Bayview Research Group, LLC
Valley Village, California
Lynn Institute of the Rockies
Colorado Springs, Colorado
Colorado Springs Family Practice
Colorado Springs, Colorado
Radiant Research, Inc.
Denver, Colorado
Norwich Pediatric Group, P.C.
Norwich, Connecticut
University of South Florida
Tampa, Florida
Emory University School of Medicine Department of Pediatrics
Atlanta, Georgia
Emory University School of Medicine
Atlanta, Georgia
Radiant Research, Inc
Atlanta, Georgia
North Georgia Clinical Research Center dba Whites Pediatrics
Dalton, Georgia
Pediatrics and Adolescent Medicine, PA
Marietta, Georgia
Pediatrics and Adolescent Medicine
Woodstock, Georgia
Advanced Clinical Research
Meridian, Idaho
Northern Illinois Research Associates
DeKalb, Illinois
Clinical Research Advantage, Inc./ Ridge Family Practice, PC
Council Bluffs, Iowa
Heartland Research Associates, LLC
Augusta, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Via Christi Clinic, P.A.
Wichita, Kansas
Kentucky Pediatric/Adult Research
Bardstown, Kentucky
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.